Skip to content
Search

Latest Stories

Charges could be introduced for rapid Covid testing from next year

The UK is reportedly aiming early next year to be ready to start charging for some previously free Covid-19 tests, a step one described as driven by the Treasury's desire to rein in spending.

The government and health officials have said that rapid testing, via easy-to-use lateral flow tests, is crucial for tracking the spread of Covid-19, with regular testing of those without symptoms identifying around a quarter of all cases.


Under the universal provision, the government has made the tests freely available to order online or pick up from community pharmacies since April, and recommends people test themselves around twice a week.

But with a budget statement later this month, the finance ministry is keen to try to reduce its spending on the pandemic, which is set to hit £407 billion.

Under the so-called winter plan, published last month, the government said it would "continue to provide the public with access to free lateral flow tests in the coming months".

"At a later stage, as the government's response to the virus changes, universal free provision of LFDs (lateral flow devices) will end, and individuals and businesses using the tests will bear the cost," it added.

The government ended free lateral flow tests for businesses in England in July. It is being speculated that steps are being taken to ready a charging system for the beginning of next year for widespread use. Those steps include ensuring that payment capabilities are available on the government's website at the beginning of January.

It is unclear when the charge would be introduced.

According to the latest available government data, for the week of September 16-22, more than 4.4 million rapid tests of asymptomatic people were registered, of which almost 50,000 were positive.

The Department of Health and Social Care has declined to say what the tests cost, citing commercial contracts but it's believed they can run to £30 for a pack of seven.

Other European countries have started to charge for the tests including Germany, which was reported to be ending their free provision this month.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less